Open original FDA record ↗Recall record
- FDA identifier
- Z-1480-2018
- Company in FDA record
- Life Technologies Corporation
- FDA record creation date
- Apr 20, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The lower concentration of the RNA panel could cause a NO CALL or FALSE NEGATIVE for the reporting of ROS1 fusion. If a physician relies on a false negative result, crizotinib could be improperly excluded from the patient's treatment regimen.
Source facts
- Action
- The firm issued an Urgent: Medical Device Recall Notification, dated February 16, 2018, via e-mail and phone call to affected consignees. The letter identified the affected device and advised customers of the potential "No Call" or false positive outcomes. Users were advised that they may need an alternate method to determine the presence of ROS1 variant in previously tested patient samples, and that any future tests using the affected lot cannot be considered valid if "No Call" or "Negative" is the result. Requested action included reviewing previous results which used the affected lot. Customers are to complete the Customer Response Sheet provided and e-mail a scanned copy along with the letter to vineet.bansal1@thermofisher.com. Questions and comments should be directed to Vineet Bansal, 408-802-2341, vineet.bansal1@thermofisher.com.
- Initiated
- 2018-02-08
- Root cause
- Process control
- Terminated
- 2020-05-12
- Distribution
- Distributed to states: AZ, CA, NC, TX, and VA.
- Recall number
- Z-1480-2018
- Recall status
- Terminated
- CDRH record ID
- 162895
- FDA record created
- 2018-04-20
- Recall event number
- 79649